Cargando…

Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial

OBJECTIVES: To assess whether social support or autonomy support intervention for patients with type 2 diabetes can achieve glycemic control at the end of intervention, and to test whether the glycemic control effect can be maintained for a long time. RESEARCH DESIGN AND METHODS: In this cluster ran...

Descripción completa

Detalles Bibliográficos
Autores principales: Yun, Qingping, Ji, Ying, Liu, Shenglan, Shen, Yang, Jiang, Xuewen, Fan, Xinyi, Liu, Jingnan, Chang, Chun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199146/
https://www.ncbi.nlm.nih.gov/pubmed/32299898
http://dx.doi.org/10.1136/bmjdrc-2019-001018
_version_ 1783529105920098304
author Yun, Qingping
Ji, Ying
Liu, Shenglan
Shen, Yang
Jiang, Xuewen
Fan, Xinyi
Liu, Jingnan
Chang, Chun
author_facet Yun, Qingping
Ji, Ying
Liu, Shenglan
Shen, Yang
Jiang, Xuewen
Fan, Xinyi
Liu, Jingnan
Chang, Chun
author_sort Yun, Qingping
collection PubMed
description OBJECTIVES: To assess whether social support or autonomy support intervention for patients with type 2 diabetes can achieve glycemic control at the end of intervention, and to test whether the glycemic control effect can be maintained for a long time. RESEARCH DESIGN AND METHODS: In this cluster randomized controlled trial, 18 community healthcare stations (CHSs) were randomized to the following: (1) usual care group (UCG) offering regular public health management services, (2) social support group (SSG) providing 3-month social support intervention based on problem solving principles, and (3) autonomy support group (ASG) offering 3-month autonomy support intervention based on self-determination theory. A total of 364 patients registered in the CHSs were enrolled into either of the three groups. The primary outcome was hemoglobin A1c (HbA1c), and secondary outcomes were diabetes self-management (DSM) behaviors. Assessment was conducted at baseline and at 3 and 6 months. RESULTS: Patients in ASG achieved better HbA1c reduction at the end of intervention (0.53% or 7.23 mmol/mol, p<0.001) than those in the UCG and successfully maintained it up to 6 months (0.42% or 5.41 mmol/mol, p<0.001). However, patients in SSG did not experience significant change in HbA1c at 3 or 6 months when compared with patients in UCG. Besides, patients in both the SSG (0.12, p<0.05) and ASG (0.22, p<0.001) experienced improvement in exercise at 3 months. Patients in ASG sustained improvement in exercise up to 6 months (0.21, p<0.001), but those in the SSG did not. CONCLUSIONS: Autonomy support for patients with type 2 diabetes could help achieve glycemic control at the end of intervention and successfully maintain it up to 6 months. These findings indicate that autonomy support has positive long-term effects on DSM behaviors and glycemic control and can be recommended in future diabetes intervention programs. TRIAL REGISTRATION NUMBER: ChiCTR1900024354.
format Online
Article
Text
id pubmed-7199146
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-71991462020-05-06 Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial Yun, Qingping Ji, Ying Liu, Shenglan Shen, Yang Jiang, Xuewen Fan, Xinyi Liu, Jingnan Chang, Chun BMJ Open Diabetes Res Care Psychosocial Research OBJECTIVES: To assess whether social support or autonomy support intervention for patients with type 2 diabetes can achieve glycemic control at the end of intervention, and to test whether the glycemic control effect can be maintained for a long time. RESEARCH DESIGN AND METHODS: In this cluster randomized controlled trial, 18 community healthcare stations (CHSs) were randomized to the following: (1) usual care group (UCG) offering regular public health management services, (2) social support group (SSG) providing 3-month social support intervention based on problem solving principles, and (3) autonomy support group (ASG) offering 3-month autonomy support intervention based on self-determination theory. A total of 364 patients registered in the CHSs were enrolled into either of the three groups. The primary outcome was hemoglobin A1c (HbA1c), and secondary outcomes were diabetes self-management (DSM) behaviors. Assessment was conducted at baseline and at 3 and 6 months. RESULTS: Patients in ASG achieved better HbA1c reduction at the end of intervention (0.53% or 7.23 mmol/mol, p<0.001) than those in the UCG and successfully maintained it up to 6 months (0.42% or 5.41 mmol/mol, p<0.001). However, patients in SSG did not experience significant change in HbA1c at 3 or 6 months when compared with patients in UCG. Besides, patients in both the SSG (0.12, p<0.05) and ASG (0.22, p<0.001) experienced improvement in exercise at 3 months. Patients in ASG sustained improvement in exercise up to 6 months (0.21, p<0.001), but those in the SSG did not. CONCLUSIONS: Autonomy support for patients with type 2 diabetes could help achieve glycemic control at the end of intervention and successfully maintain it up to 6 months. These findings indicate that autonomy support has positive long-term effects on DSM behaviors and glycemic control and can be recommended in future diabetes intervention programs. TRIAL REGISTRATION NUMBER: ChiCTR1900024354. BMJ Publishing Group 2020-04-16 /pmc/articles/PMC7199146/ /pubmed/32299898 http://dx.doi.org/10.1136/bmjdrc-2019-001018 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Psychosocial Research
Yun, Qingping
Ji, Ying
Liu, Shenglan
Shen, Yang
Jiang, Xuewen
Fan, Xinyi
Liu, Jingnan
Chang, Chun
Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title_full Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title_fullStr Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title_full_unstemmed Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title_short Can autonomy support have an effect on type 2 diabetes glycemic control? Results of a cluster randomized controlled trial
title_sort can autonomy support have an effect on type 2 diabetes glycemic control? results of a cluster randomized controlled trial
topic Psychosocial Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199146/
https://www.ncbi.nlm.nih.gov/pubmed/32299898
http://dx.doi.org/10.1136/bmjdrc-2019-001018
work_keys_str_mv AT yunqingping canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT jiying canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT liushenglan canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT shenyang canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT jiangxuewen canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT fanxinyi canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT liujingnan canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial
AT changchun canautonomysupporthaveaneffectontype2diabetesglycemiccontrolresultsofaclusterrandomizedcontrolledtrial